semaglutide and side effects GLP-1 Semaglutide: Why Smart Biomarker Monitoring Matters Comparative safety and side effects

Clinical studies have demonstrated that it can effectively regulate blood sugar levels by lowering blood sugar levels by a significant amount

Hekimi, S., Wang, Y., & No, A

The phase III REDEFINE 1 study results, released in December 2024, showed that the CagriSema treatment group lost 22.7% of their weight after 68 weeks, significantly outperforming the single-target control drugs (semaglutide group lost 16.1%, cagrilintide group lost 11.8%)

This shift ensures that any potential nausea or fatigue has subsided before your event begins

In most cases, watery diarrhea from semaglutide is short-term and manageable

The BALANCE Model was originally designed to begin in January 2027 as the Bridge's successor, giving private Part D plans a framework to cover GLP-1 obesity drugs on a sustained basis